Pediatric mortality due to nosocomial infection: a critical approach

Julia Marcia Maluf Lopes1, Eugenio Marcos Andrade Goulart, Carlos Ernesto Ferreira Starling

  • 1Department of Pediatrics, School of Medicine, Federal University of Minas Gerais, 190/Sala 4061, Santa Efigênia, Belo Horizonte, MG, Brazil. JuliaLopes@vsnet.com.br

Insights

Nosocomial infections in children are a serious risk. Inadequate antimicrobial treatment is a key factor contributing to mortality, highlighting the need for improved healthcare quality in pediatric hospitals.

Area of Science:

  • Pediatric Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Nosocomial infections pose significant risks in pediatric populations, often leading to severe outcomes.
  • Identifying predictive factors for mortality is crucial for improving patient care.

Purpose of the Study:

  • To review and synthesize literature on predictive factors for mortality associated with nosocomial infections in pediatric patients.
  • To identify modifiable risk factors to reduce hospital mortality.

Main Methods:

  • Systematic literature review of PubMed/MEDLINE, LILACS, and Cochrane databases (1996-2006).
  • Searches conducted in English, Spanish, and Portuguese using keywords related to nosocomial infection, mortality, and pediatric age groups.

Main Results:

  • Identified numerous risk factors for mortality, including specific infections (e.g., candidemia, bacteremia, MRSA, Pseudomonas aeruginosa), patient conditions (e.g., leukemia, neutropenia, multiple organ failure), and medical interventions (e.g., corticosteroid therapy, mechanical ventilation, catheter use).
  • Inadequate antimicrobial treatment emerged as a significant, modifiable contributor to mortality in critically-ill pediatric patients.
  • High APACHE II scores (>15) were also associated with increased mortality risk.

Conclusions:

  • Several factors predict mortality in pediatric nosocomial infections, with inadequate antimicrobial treatment being a key area for intervention.
  • Further research with robust epidemiological design is needed to refine prognostic models and improve healthcare quality in pediatric hospitals.
  • Reducing pediatric deaths from nosocomial infections requires targeted strategies focusing on modifiable risk factors like antimicrobial therapy.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...